上皮-间质转化通过诱导非小细胞肺癌中CD70表达促进免疫逃逸
该研究在130个非小细胞肺癌细胞系中评估免疫检查点配体表达,发现CD70在间质表型非小细胞肺癌中富集,ZEB1调控CD70启动子活性;患者样本中CD70过表达与CD3+和CD8+ T细胞浸润减少及T细胞耗竭标志物增加相关。
要点
- CD70在间质表型非小细胞肺癌体外模型中表达富集。
- EMT诱导因子ZEB1影响CD70表达并增强CD70启动子活性。
- CD70过表达在肺肉瘤样癌中尤为富集,且与T细胞浸润减少相关。
核心结论
- 结果提供证据表明CD70和ZEB1在间质表型非小细胞肺癌免疫逃逸中起关键作用,提示EMT可能不仅通过增加癌细胞可塑性还通过重编程局部肿瘤微环境免疫反应来促进癌症进展和转移。
研究设计与样本
- 研究在130个非小细胞肺癌细胞系中进行免疫检查点配体表达的计算机模拟评估。
- 体外使用CRISPR/Cas9介导的敲低和慢病毒表达评估ZEB1表达对CD70的影响。
- 分析TCGA(n=1018)和MD Anderson癌症中心数据集(n=275)的肺癌样本基因表达谱。
- 通过免疫组化和靶向RNA测序在154个非小细胞肺癌全切片样本中进行独立验证,包括55例肺肉瘤样癌。
主要发现
- CD70表达在间质表型非小细胞肺癌体外模型中富集。
- EMT诱导因子ZEB1影响CD70表达并促进CD70启动子活性增加。
- CD70过表达在间质表型非小细胞肺癌患者肿瘤样本中可见,尤其在预后不良的肺肉瘤样癌亚型中富集。
- 在这些肿瘤中,CD70表达与CD3+和CD8+ T细胞浸润减少及T细胞耗竭标志物增加相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Epithelial-to-mesenchymal transition (EMT) is associated with tumor aggressiveness, drug resistance, and poor survival in non-small cell lung cancer (NSCLC) and other cancers. The identification of immune-checkpoint ligands (ICPLs) associated with NSCLCs that display a mesenchymal phenotype (mNSCLC) could help to define subgroups of patients who may benefit from treatment strategies using immunotherapy. METHODS: We evaluated ICPL expression in silico in 130 NSCLC cell lines. In vitro, CRISPR/Cas9-mediated knockdown and lentiviral expression were used to assess the impact of ZEB1 expression on CD70. Gene expression profiles of lung cancer samples from the TCGA (n = 1018) and a dataset from MD Anderson Cancer Center (n = 275) were analyzed. Independent validation was performed by immunohistochemistry and targeted-RNA sequencing in 154 NSCLC whole sections, including a large cohort of pulmonary sarcomatoid carcinomas (SC, n = 55). RESULTS: We uncover that the expression of CD70, a regulatory ligand from the tumor necrosis factor ligand family, is enriched in mNSCLC in vitro models. Mechanistically, the EMT-inducer ZEB1 impacted CD70 expression and fostered increased activity of the CD70 promoter. CD70 overexpression was also evidenced in mNSCLC patient tumor samples and was particularly enriched in SC, a lung cancer subtype associated with poor prognosis. In these tumors, CD70 expression was associated with decreased CD3+ and CD8+ T-cell infiltration and increased T-cell exhaustion markers. CONCLUSION: Our results provide evidence on the pivotal roles of CD70 and ZEB1 in immune escape in mNSCLC, suggesting that EMT might promote cancer progression and metastasis by not only increasing cancer cell plasticity but also reprogramming the immune response in the local tumor microenvironment.
引用
- Ortiz-Cuaran S, Swalduz A, Foy JP, et al. Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer. Eur J Cancer. 2022. PMID: 35550950. doi:10.1016/j.ejca.2022.03.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。